APLN and Wilson disease: Renal β-catenin signaling is activated, as characterized by the increase of nuclear β-catenin abundance in both cortex and medulla following WD (Lu et al., 2016), which was blocked by apelin-13, accompanied with downregulation of renal AQP2 expression in WD mice.